Vitamin B12 partially rescues embryonic cell migration defects in Caenorhabditis elegans ephrin mutants by improving propionic acid breakdown and one-carbon cycle metabolism
GENETICS · 2025
DOI: 10.1093/genetics/iyaf054 ↗Kurz gefasst
Fachartikel in der Zeitschrift GENETICS, 2025. Verfasst von Tushar H Ganjawala und 5 weiteren Autor:innen. Beteiligte Einrichtung: Divisions of Pulmonary Biology and Developmental Biology, Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, U…. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Vitamin B 12, Cell Movement, Caenorhabditis elegans Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIGMS NIH HHS, CCHMC Trustee Award.
Abstract (Originalsprache)
Successful cell migration followed by cell adhesion and tissue remodeling is required for organogenesis in a number of tissues, many of which are susceptible to gene-environment interactions resulting in congenital anomalies. In Caenorhabditis elegans embryogenesis, one such event is the closure of the ventral cleft, an essential first step in morphogenesis; this process depends on ephrin signaling, but no single gene mutation is fully penetrant embryonic lethal, likely due to redundancy with semaphorin and Robo signaling. We exposed hermaphrodites mutant for vab-1, the C. elegans ephrin receptor, to various environmental conditions and found vitamin B12 supplementation could partially rescue the embryonic lethality of multiple alleles, improving survival by 58%. Vitamin B12 improved the frequency of ventral cleft closure by promoting cell positions more similar to wild type and increasing cell migration. We found vitamin B12 partially rescued the embryonic lethality of other ephrin pathway mutants as well as semaphorin and robo mutants, but not mutants with ventral cleft defects due to cell adhesion or cell fate defects. We found rescue by vitamin B12 depends on its functions in both mitochondrial propionic acid breakdown and the one-carbon cycle, and antioxidant treatment can also partially rescue ephrin pathway mutants. These results are distinct from the larval response to vitamin B12, which depends only on the one-carbon cycle, emphasizing the unique metabolism of embryos and particularly the metabolic needs of migrating cells. Overall, our findings highlight the C. elegans embryo as a model system to investigate gene-environment interactions and developmental metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Divisions of Pulmonary Biology and Developmental Biology, Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
- Department of Pediatrics, University of Cincinnati College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.
ORCID-Profile: Tushar H Ganjawala, Amanda L Zacharias
Förderung
- NIH HHS
- NIGMS NIH HHS
- CCHMC Trustee Award
- NIH
Zitieren
APA
Ganjawala, T. H., Hsiao, E., Amom, P., Molaei, R., Goodwin, S., & Zacharias, A. L. (2025). Vitamin B12 partially rescues embryonic cell migration defects in Caenorhabditis elegans ephrin mutants by improving propionic acid breakdown and one-carbon cycle metabolism. GENETICS. https://doi.org/10.1093/genetics/iyaf054
Vancouver
Ganjawala TH, Hsiao E, Amom P, Molaei R, Goodwin S, Zacharias AL. Vitamin B12 partially rescues embryonic cell migration defects in Caenorhabditis elegans ephrin mutants by improving propionic acid breakdown and one-carbon cycle metabolism. GENETICS. 2025. doi:10.1093/genetics/iyaf054
BibTeX
@article{Ganjawala2025,
author = {Ganjawala, Tushar H and Hsiao, Erin and Amom, Prativa and Molaei, Radmehr and Goodwin, Samantha and Zacharias, Amanda L},
title = {Vitamin B12 partially rescues embryonic cell migration defects in Caenorhabditis elegans ephrin mutants by improving propionic acid breakdown and one-carbon cycle metabolism},
journal = {GENETICS},
year = {2025},
doi = {10.1093/genetics/iyaf054}
}
EUVIMED